Nanosonics Limited

ASX:NAN ISIN:AU000000NAN9

Nanosonics Limited is developing a portfolio of decontamination products designed to reduce the spread of infection. The Company owns intellectual property relating to a unique disinfection and sterilisation technology which can be suited to a variety of markets.

Initial market applications are designed for the reprocessing of reusable medical instruments. The Company’s first product is designed to disinfect Ultrasound Transducers. In parallel with the commercialisation of this product, Nanosonics is also developing other medical applications and exploring opportunities for its proprietary technology in other industries. 
 
   

다른 언어로 보기

뉴스

3월30일 아시아 시장동향

🕔3/30/2009 3:00:25 PM 19185

대부분의 아시아 증시는 금요일 미증시 하락 이후 월요일 높은 변동세로 출발했다. 도쿄와 서울 증시는 보합세로 출발했으나 곧 하락세로 전환되었다. 오늘 투자자들은 미 정부의 자동차산업 지원안 발표를 기대하고 있다.

전체 기사 읽기
###

30,868 회사 소개

  • 검색 횟수: (지난 7일간: 11) (지난 30일간: 45) (게재 이후: 6581) 

회사 데이터

더 많은 뉴스 보기

  • 2024/03/25: Change of Director's Interest Notice*
  • 2024/03/15: Organisational Announcement Chief Technology Officer*
  • 2024/03/14: Ceasing to be a substantial holder for NAN*
  • 2024/03/08: Application for quotation of securities - NAN*
  • 2024/03/05: Change in substantial holding from MUFG*
  • 2024/03/04: Change in substantial holding*
  • 2024/03/04: Change of Director's Interest Notice*
  • 2024/03/04: Change of Director's Interest Notice*
  • 2024/02/29: Change of Director's Interest Notice*
  • 2024/02/29: Change of Director's Interest Notice*
*refer to company website